Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease

Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease

Abstract Background Administering anti-vascular endothelial growth factor (anti-VEGF) by intraocular injection has been shown to have a safe systemic profile. Nevertheless, incidents of acute kidney injury following anti-VEGF injection have been reported. We assessed the long-term effect of multiple...

Full description

Bibliographic Details
Main Authors: Rachael Ann O’Neill, Patrick Gallagher, Tricia Douglas, Julie-Anne Little, Alexander Peter Maxwell, Giuliana Silvestri, Gareth McKay
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Nephrology
Subjects:
Intravitreal anti-vascular endothelial growth factor
Diabetic macular oedema
Renal function
Online Access:https://doi.org/10.1186/s12882-019-1650-1

Similar Items

Similar Items